Compass Group PLC
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Compass Group PLC (CMPGY) is a leading global provider of foodservices and support services, operating primarily in the business and industry; healthcare and seniors; education; and sports and leisure sectors. The company offers a comprehensive range of services including contract catering, food preparation and supply, hospitality management, facilities support, cleaning and hygiene services, property management, laundry services, grounds maintenance, and employee vending; it manages client dining facilities, workplace cafeterias, healthcare nutrition programs, educational meal services, stadium concessions, and premium hospitality experiences under brands such as Chartwells, Eurest, and Morrison Healthcare. Compass serves corporate offices, hospitals, universities, schools, stadiums, and leisure venues worldwide, with operations spanning North America, Europe, Asia Pacific, and other regions; founded in 1941 and headquartered in Chertsey, United Kingdom, it employs over 500,000 people across more than 45 countries. In recent developments, Compass has expanded through strategic acquisitions such as Gourmet Meals in Australia in 2024 to bolster its healthcare segment, launched innovative sustainability initiatives including net-zero commitments by 2050 with key partnerships in renewable energy sourcing, and strengthened its digital offerings with new AI-driven menu planning and inventory management tools rolled out globally in 2025; additionally, the company announced a major alliance with a leading sports league for enhanced stadium operations in North America during fiscal year 2025.
Compass Therapeutics to Participate in Upcoming June Investor Events
Compass Pathways Elects Kathleen Tregoning to Board of Directors
Compass Pathways: A Trip Worth Taking Before The FDA Verdict
Compass: Profit Can Multiply When Housing Market Recovers
Compass Therapeutics to Present Promising Phase 1 Clinical Data for CTX-8371 in Patients with Advanced Malignancies Treated in the Post-Checkpoint Inhibitor Setting at the 2026 ASCO Annual Meeting
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Compass Therapeutics, Inc. - CMPX
Compass Pathways Eyes Q4 FDA Filing for Psilocybin Depression Drug After Phase 3 Wins
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Compass Therapeutics, Inc. - CMPX
Compass Lexecon Expands Antitrust Expertise With Addition of Two Affiliates
AI/R Compass UOL Advances the Application of AI in DevOps and Earns Recognition from Amazon Web Services
EnergyX Signs Agreement with Compass Minerals to Advance up to 30,000-ton Commercial Lithium DLE Facility in Utah
Exclusive: Compass Minerals eyes return to lithium market with EnergyX partnership
Compass Lexecon Adds Leading Competition and Regulatory Economist in London
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Compass Therapeutics, Inc. - CMPX
Compass Pathways: Imminent Commercialization Should Provide Further Upside
Compass Group Selected as the University of Kentucky's Preferred Partner to Advance a New Model for Integrated Campus and Healthcare Services
Compass Pathways to Participate in RBC Capital Markets Global Healthcare Conference on May 19-20, 2026
Compass Minerals Announces Participation in Deutsche Bank's 17th Annual Basic Materials Conference in June 2026
Compass Pathways shares rise on Q1 results, accelerated FDA review
Compass Pathways Q1 Earnings Call Highlights